FDA updates labeling for ARYNTA
Labeling changes approved for AZURITY. Active ingredient: LISDEXAMFETAMINE DIMESYLATE. Decision date: 12/22/2025
Labeling changes approved for AZURITY. Active ingredient: LISDEXAMFETAMINE DIMESYLATE. Decision date: 12/22/2025
There are no comments here yet...